{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:19:05Z","timestamp":1792819145170,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07588-2","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:28:24Z","timestamp":1760927304000},"page":"1902-1912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond PSMA: The essential complementary role of MRI in staging prostate cancer with Low-PSMA expression phenotypes"],"prefix":"10.1007","volume":"53","author":[{"given":"Ruohua","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"issue":"1","key":"7588_CR1","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7588_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","volume":"46","author":"P Donato","year":"2019","unstructured":"Donato P, Roberts MJ, Morton A, Kyle S, Coughlin G, Esler R, et al. Improved specificity with (68)Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2019;46(1):20\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"7588_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/cpf.12480","volume":"38","author":"HD Zacho","year":"2018","unstructured":"Zacho HD, Nielsen JB, Haberkorn U, Stenholt L, Petersen LJ. (68) Ga-PSMA PET\/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature. Clin Physiol Funct Imaging. 2018;38(6):911\u201322.","journal-title":"Clin Physiol Funct Imaging."},{"issue":"4","key":"7588_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"M van der Leest","year":"2019","unstructured":"van der Leest M, Cornel E, Israel B, Hendriks R, Padhani AR, Hoogenboom M, et al. Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naive men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol. 2019;75(4):570\u20138.","journal-title":"Eur Urol"},{"key":"7588_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.radonc.2019.07.005","volume":"141","author":"AS Bettermann","year":"2019","unstructured":"Bettermann AS, Zamboglou C, Kiefer S, Jilg CA, Spohn S, Kranz-Rudolph J, et al. (68)Ga-]PSMA-11 PET\/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - implications for focal radiotherapy planning in primary prostate cancer. Radiother Oncol. 2019;141:214\u20139.","journal-title":"Radiother Oncol"},{"issue":"12","key":"7588_CR6","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1007\/s00259-016-3435-0","volume":"43","author":"T Pyka","year":"2016","unstructured":"Pyka T, Okamoto S, Dahlbender M, Tauber R, Retz M, Heck M, et al. Comparison of bone scintigraphy and (68)Ga-PSMA PET for skeletal staging in prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43(12):2114\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7588_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MNM.0000000000001485","volume":"43","author":"NP Karahan Sen","year":"2022","unstructured":"Karahan Sen NP, Aksu A, Bozkurt O, Tuna EB, Capa Kaya G. Interreader agreement in evaluation of 68Ga-PSMA PET\/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups. Nucl Med Commun. 2022;43(1):86\u201391.","journal-title":"Nucl Med Commun"},{"issue":"6","key":"7588_CR8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s00259-017-3670-z","volume":"44","author":"WP Fendler","year":"2017","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Ceci F, Cho S, et al. (68)Ga-PSMA PET\/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44(6):1014\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7588_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1602412","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Wang S, Wang J, Qi X, Liu T, He X, et al. PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis. Front Oncol. 2025;15:1602412.","journal-title":"Front Oncol"},{"key":"7588_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2018.00074","volume":"5","author":"R Muteganya","year":"2018","unstructured":"Muteganya R, Goldman S, Aoun F, Roumeguere T, Albisinni S. Current imaging techniques for lymph node staging in prostate cancer: a review. Front Surg. 2018;5:74.","journal-title":"Front Surg"},{"issue":"6","key":"7588_CR11","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.2214\/AJR.15.15761","volume":"206","author":"S Woo","year":"2016","unstructured":"Woo S, Kim SY, Kim SH, Cho JY. Journal club: identification of bone metastasis with routine prostate MRI: a study of patients with newly diagnosed prostate cancer. AJR Am J Roentgenol. 2016;206(6):1156\u201363.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"7588_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-018-4255-1","volume":"46","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shao S, Wu P, Liu D, Yang B, Han D, et al. Diagnostic performance of (68)Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging. 2019;46(4):908\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7588_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00256-019-03230-z","volume":"48","author":"J Zhou","year":"2019","unstructured":"Zhou J, Gou Z, Wu R, Yuan Y, Yu G, Zhao Y. Comparison of PSMA-PET\/CT, choline-PET\/CT, NaF-PET\/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis. Skeletal Radiol. 2019;48(12):1915\u201324.","journal-title":"Skeletal Radiol"},{"issue":"3","key":"7588_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed mitnm classification for the interpretation of PSMA-ligand PET\/CT. J Nucl Med. 2018;59(3):469\u201378.","journal-title":"J Nucl Med"},{"issue":"7","key":"7588_CR15","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s00261-019-02006-2","volume":"44","author":"MAA Basha","year":"2019","unstructured":"Basha MAA, Hamed MAG, Hussein O, El-Diasty T, Abdelkhalek YI, Hussein YO, et al. (68)Ga-PSMA-11 PET\/CT in newly diagnosed prostate cancer: diagnostic sensitivity and interobserver agreement. Abdom Radiol. 2019;44(7):2545\u201356.","journal-title":"Abdom Radiol"},{"issue":"1","key":"7588_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jmrs.227","volume":"64","author":"L Emmett","year":"2017","unstructured":"Emmett L, Willowson K, Violet J, Shin J, Blanksby A, Lee J. Lutetium (177) PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy. J Med Radiat Sci. 2017;64(1):52\u201360.","journal-title":"J Med Radiat Sci"},{"issue":"7","key":"7588_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.urolonc.2016.03.001","volume":"34","author":"ER Felker","year":"2016","unstructured":"Felker ER, Margolis DJ, Nassiri N, Marks LS. Prostate cancer risk stratification with magnetic resonance imaging. Urol Oncol. 2016;34(7):311\u20139.","journal-title":"Urol Oncol"},{"issue":"1","key":"7588_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.acra.2018.03.024","volume":"26","author":"S Gaur","year":"2019","unstructured":"Gaur S, Harmon S, Gupta RT, Margolis DJ, Lay N, Mehralivand S, et al. A multireader exploratory evaluation of individual pulse sequence cancer detection on prostate multiparametric magnetic resonance imaging (MRI). Acad Radiol. 2019;26(1):5\u201314.","journal-title":"Acad Radiol"},{"issue":"1","key":"7588_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bju.14858","volume":"126","author":"AA Kalapara","year":"2020","unstructured":"Kalapara AA, Nzenza T, Pan HYC, Ballok Z, Ramdave S, O\u2019Sullivan R, et al. Detection and localisation of primary prostate cancer using (68) gallium prostate-specific membrane antigen positron emission tomography\/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology. BJU Int. 2020;126(1):83\u201390.","journal-title":"BJU Int"},{"issue":"12","key":"7588_CR20","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1007\/s00259-021-05501-1","volume":"48","author":"JH Ruschoff","year":"2021","unstructured":"Ruschoff JH, Ferraro DA, Muehlematter UJ, Laudicella R, Hermanns T, Rodewald AK, et al. What\u2019s behind (68)Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns. Eur J Nucl Med Mol Imaging. 2021;48(12):4042\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7588_CR21","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.21037\/qims-20-1312","volume":"11","author":"LP Qin","year":"2021","unstructured":"Qin LP, Lv J, Li MZ, Xie LJ, Li JP, Li JF, et al. Biphasic GA 68-labeled prostate specific membrane antigen-11 positron emission tomography\/computed tomography scans in the differential diagnosis and risk stratification of initial primary prostate cancer. Quant Imaging Med Surg. 2021;11(8):3619\u201328.","journal-title":"Quant Imaging Med Surg"},{"key":"7588_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102788","author":"MA Hoffmann","year":"2020","unstructured":"Hoffmann MA, Buchholz HG, Wieler HJ, Rosar F, Miederer M, Fischer N, et al. Dual-time point [(68)Ga]Ga-PSMA-11 PET\/CT hybrid imaging for staging and restaging of prostate cancer. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12102788.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7588_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-022-01217-4","volume":"13","author":"R Laudicella","year":"2022","unstructured":"Laudicella R, Skawran S, Ferraro DA, Muhlematter UJ, Maurer A, Grunig H, et al. Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients. Insights Imaging. 2022;13(1):75.","journal-title":"Insights Imaging"},{"issue":"2","key":"7588_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","volume":"15","author":"S Mannweiler","year":"2009","unstructured":"Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D, Mehes G. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res. 2009;15(2):167\u201372.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"7588_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","volume":"63","author":"AM Hovels","year":"2008","unstructured":"Hovels AM, Heesakkers RA, Adang EM, Jager GJ, Strum S, Hoogeveen YL, et al. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol. 2008;63(4):387\u201395.","journal-title":"Clin Radiol"},{"issue":"11","key":"7588_CR26","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1007\/s00259-022-05831-8","volume":"49","author":"W Cytawa","year":"2022","unstructured":"Cytawa W, Kircher S, Kubler H, Werner RA, Weber S, Hartrampf P, et al. Diverse PSMA expression in primary prostate cancer: reason for negative [(68)Ga]Ga-PSMA PET\/CT scans? Immunohistochemical validation in 40 surgical specimens. Eur J Nucl Med Mol Imaging. 2022;49(11):3938\u201349.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"7588_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pros.22742","volume":"74","author":"G Gandaglia","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, Trudeau V, Shariat SF, Kim SP, et al. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014;74(2):210\u20136.","journal-title":"Prostate"},{"issue":"3","key":"7588_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.juro.2017.11.095","volume":"199","author":"MG Sanda","year":"2018","unstructured":"Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline. Part I: risk stratification, shared decision making, and care options. J Urol. 2018;199(3):683\u201390.","journal-title":"J Urol"},{"issue":"2","key":"7588_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000335205","volume":"88","author":"F Pinto","year":"2012","unstructured":"Pinto F, Totaro A, Palermo G, Calarco A, Sacco E, D\u2019Addessi A, et al. Imaging in prostate cancer staging: present role and future perspectives. Urol Int. 2012;88(2):125\u201336.","journal-title":"Urol Int"},{"issue":"17","key":"7588_CR30","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/jnci\/djt175","volume":"105","author":"DV Makarov","year":"2013","unstructured":"Makarov DV, Loeb S, Ulmert D, Drevin L, Lambe M, Stattin P. Prostate cancer imaging trends after a nationwide effort to discourage inappropriate prostate cancer imaging. J Natl Cancer Inst. 2013;105(17):1306\u201313.","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07588-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07588-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:33Z","timestamp":1769834613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07588-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7588"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07588-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was in line with principles of ethics committee in Renji hospital and the declaration of Helsinki in 1964. Animal-based research was not included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflict of interest was reported.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}